Skip to main content

15 Result(s)

within A. Lièvre Remove this filter

and

  1. No Access

    Article

    Revue de presse

    V. de Parades, J. -D. Zeitoun, A. Dubois, N. Musquer, E. Cotte, M. Simon… in Côlon & Rectum (2017)

  2. No Access

    Article

    Revue de presse

    V. de Parades, Y. Panis, G. Meurette, J. -D. Zeitoun, L. Siproudhis… in Côlon & Rectum (2017)

  3. No Access

    Article

    Compte-rendu du congrès de l’ASCO 2016

    T. Aparicio, A. Lièvre, F. Bibeau in Côlon & Rectum (2016)

  4. No Access

    Article

    Controverse

    E. Cotte, A. Lièvre in Côlon & Rectum (2016)

  5. No Access

    Article

    Revue De Presse

    V. de Parades, F. Pigot, J. D. Zeitoun, J. H. Lefevre, Q. Denost… in Côlon & Rectum (2016)

  6. No Access

    Article

    Revue de presse

    A. Senéjoux, T. Walter, D. Bouchard, F. Pigot, E. Cotte, A. Lièvre… in Côlon & Rectum (2016)

  7. No Access

    Article

    Revue de presse

    A. Senéjoux, V. de Parades, T. Walter, D. Bouchard, Y. Panis, A. Lièvre… in Côlon & Rectum (2016)

  8. No Access

    Article

    Des mutations de KRAS aux mutations de RAS : vers une meilleure définition de la réponse aux anticorps anti-EGFR dans le cancer colorectal métastatique

    L’identification des mutations de KRAS comme facteur prédictif de résistance aux anticorps anti-EGFR a permis de faire un grand pas dans la personnalisation du traitement du cancer colorectal métastatique. Réc...

    A. Lièvre in Oncologie (2014)

  9. No Access

    Article

    Three different KRAS statuses in three synchronous colorectal cancers

    Treatments with monoclonal antibodies targeting the epidermal growth factor receptors (EGFR) have improved the prognosis of metastatic colorectal cancer (CRC). Mutated KRAS status is predictive of resistance t...

    L. Jolissaint, W. Cacheux, P. Mariani, C. Le Tourneau, A. Lièvre… in Medical Oncology (2012)

  10. No Access

    Article

    Tumeurs digestives

    A. Lièvre in Oncologie (2012)

  11. No Access

    Article

    Vers un traitement personnalisé du cancer colorectal: facteurs pronostiques et prédictifs

    Colorectal cancer (CRC) remains a major public health problem despite the advent of several conventional chemotherapies and targeted therapies. The identification of prognostic factors, and also factors that c...

    A. Lièvre in Oncologie (2010)

  12. No Access

    Article

    Oncogenic mutations as predictive factors in colorectal cancer

    The anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies cetuximab and panitumumab have been demonstrated to be new therapeutic options for metastatic colorectal cancer (mCRC). Oncogenic act...

    A Lièvre, H Blons, P Laurent-Puig in Oncogene (2010)

  13. No Access

    Article

    Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab

    G. El Maalouf, E. Mitry, A. Lacout, A. Lièvre, P. Rougier in Journal of Neurology (2008)

  14. No Access

    Article

    Traitements adjuvant et néoadjuvant des cancers du rectum

    En cas de cancer du rectum, les objectifs principaux d’un traitement préopératoire sont de diminuer le risque de rechute locale, de permettre une chirurgie conservatrice et, si possible, d’améliorer la survie ...

    E. Mitry, A. Lièvre, P. Rougier in Côlon & Rectum (2007)

  15. Article

    Open Access

    Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma

    Mitochondrial DNA mutations have been reported in several types of tumours, including head and neck squamous cell carcinoma (HNSCC). The noncoding region of the Displacement-Loop (D-Loop) has emerged as a muta...

    A Lièvre, H Blons, A M Houllier, O Laccourreye, D Brasnu… in British Journal of Cancer (2006)

    Download PDF (147 KB) View Article